VANCOUVER, April 17, 2018 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced completion of enrollment for the Phase 4 SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the Company’s antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), in the post-authorization […]
Other News
Intact Vascular Announces $20 Million Series C Financing to Fund Company through PMA Approval of the Tack Endovascular System®
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it closed a Series C financing totaling $20 million. This financing is designed to fund the Company through Pre-Market Approval (“PMA”) of the Tack Endovascular System for the treatment of post-angioplasty […]
LimFlow Raises €27 Million ($33.5 Million) in Series C Financing Led by Sofinnova Partners to Advance Innovative Critical Limb Ischemia (CLI) Treatment
PARIS–(BUSINESS WIRE)–LimFlow SA, developer of innovative, peripheral endovascular technology transforming the treatment of critical limb ischemia (CLI), today announced it has secured €27 million ($33.5 million) in an oversubscribed Series C financing. The round was led by Sofinnova Partners, with continued participation from existing round B investors Bpifrance, the French […]
Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification
DANVERS, Mass., April 13, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, May 3, 2018, the Company will release financial results for the fourth quarter of fiscal 2018. The Company will host a conference call to discuss the results on Thursday, May 3, 2018, at 8:00 a.m. EDT. […]
Asahi Intecc To Begin Direct Sales Of Its Coronary Guide Wires
TUSTIN, Calif., April 12, 2018 /PRNewswire/ — Asahi Intecc USA, Inc. will begin direct sales of its coronary (PTCA) guide wires in the US. These guide wires are currently distributed by Abbott Vascular. As of July 1, 2018 the entire portfolio of Asahi PTCA guide wires will also be available directly from Asahi. All sales requests prior to July 1 should continue to be directed […]
CHF Solutions, Inc. Expands Operations into Hong Kong; Receives First Commercial Orders for Both Hong Kong and Singapore
EDEN PRAIRIE, Minn., April 12, 2018 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq:CHFS) announced today its commercial expansion into the Hong Kong market through its Asia distributor, Transmedic. Further, Transmedic has confirmed its first commercial orders for both Singapore and Hong Kong. “Our expansion into the Asian markets is a key […]
Bluegrass Vascular Welcomes First Reporting Standards For Thoracic Central Vein Obstruction
SAN ANTONIO, April 13, 2018 /PRNewswire/ — Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, today welcomed the publication of the first reporting standards for thoracic central vein obstruction (TCVO) in the Journal of Vascular and Interventional Radiology (JVIR). The document is also […]
Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 third-quarter conference call on Wednesday, May 2, 2018, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fiscal third quarter ended March 31, 2018, and its financial […]
HeartStitch® Inc. has received CE Mark for Its Suture Based Trans-Apical Access and Closure
ZWICKAU, Germany, April 12, 2018 /PRNewswire/ — HeartStitch® Trans-Apical Access and Closure device provides safe and effective percutaneous trans-apical access for structural heart procedures and reliable closure. The proven suture-based technique emulates surgical closure without the need for open heart surgery or limited thoracotomy access (open surgical access to the heart between the ribs) when […]
Ventricular Assist Devices Market Expected to Reach $1,773 Million, Globally, by 2023 – Allied Market Research
PORTLAND, Oregon and PUNE, India, April 12, 2018 /PRNewswire/ — According to a new report published by Allied Market Research, titled, ” Ventricular Assist Devices Market by Product, Application, and Design: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global ventricular assist devices market was valued at $809 million in 2016, and is estimated to reach $1,773 million by […]



